ArticleEuropean journal of pharmacology2015

The xanthine oxidase inhibitor Febuxostat reduces tissue uric acid content and inhibits injury-induced inflammation in the liver and lung.

Hiroshi Kataoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.